Earnings Feed
Start Free
GILEAD SCIENCES, INC.·4

Mar 12, 4:42 PM ET

Mercier Johanna 4

4 · GILEAD SCIENCES, INC. · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Gilead (GILD) Officer Johanna Mercier Exercises Options, Receives RSUs

What Happened Johanna Mercier, Chief Communications & Corporate Affairs Officer at Gilead Sciences (GILD), exercised/converted derivative awards and received new restricted stock unit (RSU) awards on March 10, 2026. The filing shows an exercise/conversion of 6,617 option-derived shares and grants/awards totaling 45,470 RSU-type shares (9,590 and 35,880). To cover tax withholding related to the transaction, 3,216 shares were surrendered/ disposed at $148.56 per share, generating proceeds of $477,769.

Key Details

  • Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely within typical 2-business-day window).
  • Exercises/conversions: 6,617 shares (derivative exercise).
  • Awards/grants received: 9,590 RSU-equivalent shares and 35,880 RSU-equivalent shares (both marked as derivative/award). The 35,880 award shows $0.00 per share (no cash paid).
  • Tax withholding/covering: 3,216 shares were disposed at $148.56 to satisfy tax liabilities, totaling $477,769. (Transaction code F = tax withholding.)
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Footnotes:
    • F1: Each RSU represents a contingent right to one share of common stock.
    • F2: RSUs vest over four years (25% at year one, then 6.25% quarterly).
    • F3: Stock options vest over four years (25% at year one, then 6.25% quarterly).

Context

  • This was effectively an option exercise and RSU grant combined with a typical "sell/withhold to cover taxes" (the 3,216-share disposal) rather than an open-market sale for investment purposes. Such tax-withholding disposals are routine following option exercises or vesting events.
  • Derivative transactions (M) indicate exercise/conversion of options or other derivative awards; the RSU lines (A) are grants/awards that convert to shares per the vesting schedule above.
  • The filing provides facts about the transactions but does not indicate motivation or future outlook.

Insider Transaction Report

Form 4
Period: 2026-03-10
GILEAD SCIENCES, INC.GILD
Mercier Johanna
Chief Comm & Corp Aff Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-10+6,617→ 137,995 total
  • Tax Payment

    Common Stock

    2026-03-10$148.56/sh−3,216$477,769→ 134,779 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F2]
    2026-03-10−6,617→ 21,057 total
    → Common Stock (6,617 underlying)
  • Award

    Restricted Stock Unit

    [F1][F2]
    2026-03-10+9,590→ 30,647 total
    → Common Stock (9,590 underlying)
  • Award

    Non-qualified Stock Option (Right to Buy)

    [F3]
    2026-03-10+35,880→ 35,880 total
    Exercise: $148.56Exp: 2036-03-10→ Common Stock (35,880 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
  • [F3]The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Signature
/s/ Amy Kim by Power of Attorney for Johanna Mercier|2026-03-12

Documents

1 file
  • 4
    wk-form4_1773348121.xmlPrimary

    FORM 4